Methodological shortcomings predicted lower harm estimates in one of two sets of studies of clinical interventions
Authors:
- 1 January 2007
- journal article
- research article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 60 (1) , 18-28
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Reporting of Harm in Randomized, Controlled Trials of Nonpharmacologic Treatment for Rheumatic DiseaseAnnals of Internal Medicine, 2005
- External validity of randomised controlled trials: “To whom do the results of this trial apply?”The Lancet, 2005
- The Risk and Benefit of Endarterectomy in Women With Symptomatic Internal Carotid Artery DiseaseStroke, 2005
- Risk of cardiovascular events and rofecoxib: cumulative meta-analysisThe Lancet, 2004
- Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug ReactionsJAMA, 2004
- The road to health careBMJ, 2004
- Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished dataThe Lancet, 2004
- Surgeon Volume and Operative Mortality in the United StatesNew England Journal of Medicine, 2003
- Completeness of Safety Reporting in Randomized TrialsJAMA, 2001
- Reporting of Adverse Effects in Clinical Trials Should Be ImprovedJournal of Pain and Symptom Management, 1999